ProMIS Neurosciences Inc.
ProMIS Neurosciences Inc. (PMN): 1 pipeline candidate · ~16 mo cash runway · 2 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
15.6 months
D/E 0.11 · 0% dilution
Lead: Phase 1
1 candidate
N/A
7 buys · 0 sells (180d)
A transparent, data-derived signal for ProMIS Neurosciences Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$90.1M
Cash
$63.8M
Quarterly Burn
$12.4M
Runway
15.6 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| pmn310 | Phase 1 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
20
Total value held
$68.8M
| Holder | Shares | Value |
|---|---|---|
| janus henderson group plc | 2,585,514 | $32.8M |
| deep track capital, lp | 835,655 | $10.6M |
| wellington management group llp | 696,378 | $8.8M |
| great point partners llc | 371,402 | $4.7M |
| sphera funds management ltd. | 325,591 | $4.1M |
| adage capital partners gp, l.l.c. | 139,275 | $1.8M |
| adar1 capital management, llc | 95,350 | $1.2M |
| 683 capital management, llc | 92,850 | $1.2M |
| millennium management llc | 77,921 | $990K |
| empery asset management, lp | 60,353 | $766K |
Showing top 10 of 20 institutional holders of ProMIS Neurosciences Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in ProMIS Neurosciences Inc.'s pipeline?
ProMIS Neurosciences Inc. (PMN) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is ProMIS Neurosciences Inc.'s lead drug candidate?
ProMIS Neurosciences Inc.'s most advanced tracked candidate is pmn310 (Phase 1) for Alzheimer Disease, Early Onset; Healthy Participants.
What is ProMIS Neurosciences Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, ProMIS Neurosciences Inc. has approximately 15.6 months of cash runway.
What is ProMIS Neurosciences Inc.'s market capitalization?
ProMIS Neurosciences Inc.'s market capitalization is approximately $90.1M.
Who is the CEO of ProMIS Neurosciences Inc.?
Mr. Neil K. Warma M.B.A. is the chief executive officer of ProMIS Neurosciences Inc. (PMN).
Get the full picture on ProMIS Neurosciences Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.